Vicore Pharma Holding AB's total assets for Q4 2024 were kr1.20B, an increase of 195.68% from the previous quarter. DE:6Y4 total liabilities were kr73.78M for the fiscal quarter, a 152.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.